---
figid: PMC6107487__13238_2017_500_Fig8_HTML
figtitle: Pirh2 mediate the sensitivity of myeloma cells to bortezomib via the canonical
  NFKB signaling pathway
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC6107487
filename: 13238_2017_500_Fig8_HTML.jpg
figlink: /pmc/articles/PMC6107487/figure/Fig8/
number: F8
caption: Pirh2 mediate the sensitivity of myeloma cells to bortezomib via the canonical
  NF-κB signaling pathway
papertitle: Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical
  NF-κB signaling pathway.
reftext: Li Yang, et al. Protein Cell. 2018 Sep;9(9):770-784.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9318899
figid_alias: PMC6107487__F8
figtype: Figure
redirect_from: /figures/PMC6107487__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6107487__13238_2017_500_Fig8_HTML.html
  '@type': Dataset
  description: Pirh2 mediate the sensitivity of myeloma cells to bortezomib via the
    canonical NF-κB signaling pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATPsynbeta
  - Atpalpha
  - Dif
  - dl
  - Rel
  - Hrb27C
  - betaTub60D
  - Rpt5
  - DCTN2-p50
  - wash
  - E3
  - IKKepsilon
  - key
  - IKKbeta
  - ATP8A2
  - NFKB1
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - NFKBIA
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - RCHY1
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - ATP
  - Bortezomib
---
